305
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Patterns of Bone Marrow Confirmed Malignant and Non-Malignant Hematological Disorders in Patients with Abnormal Hematological Parameters in Northeast Ethiopia

ORCID Icon, ORCID Icon, & ORCID Icon
Pages 51-60 | Published online: 15 Feb 2022

References

  • Joshi S, Wader J, Kanethkar S. Bone marrow aspiration and bone marrow biopsy in hematological disorders. Biomed Pharmacol J. 2020;13(02):799–804. doi:10.13005/bpj/1944
  • Khan MI, Yasmeen N, Fatima SH. The spectrum of malignant and non-malignant hematological disorders in a tertiary care centre. Int J Res Med Sci. 2018;6(7):2361–2364. doi:10.18203/2320-6012.ijrms20182817
  • Rodriguez-Abreu D, Bordoni A, Zucca E. Epidemiology of hematological malignancies. Ann Oncol. 2007;18(supl1):i3–i8. doi:10.1093/annonc/mdl443
  • Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375–2390. doi:10.1182/blood-2016-01-643569
  • Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391–2405. doi:10.1182/blood-2016-03-643544
  • Harris NL, Jaffe ES, Diebold J, et al. The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Mod Pathol. 2000;13(2):193–207. doi:10.1038/modpathol.3880035
  • Davis AS, Viera AJ, Mead MD. Leukemia: an overview for primary care. Am Fam Physician. 2014;89(9):8.
  • Taylor J, Xiao W, Abdel-Wahab O. Diagnosis and classification of hematologic malignancies on the basis of genetics. Blood. 2017;130(4):410–423. doi:10.1182/blood-2017-02-734541
  • Hossain MS, Iqbal MS, Khan MA, et al. Diagnosed hematological malignancies in Bangladesh - a retrospective analysis of over 5000 cases from 10 specialized hospitals. BMC Cancer. 2014;14(1):438. doi:10.1186/1471-2407-14-438
  • Huang S-Y, Yao M, Tang J-L, et al. Epidemiology of multiple myeloma in Taiwan: increasing incidence for the past 25 years and higher prevalence of extramedullary myeloma in patients younger than 55 years. Cancer. 2007;110(4):896–905. doi:10.1002/cncr.22850
  • Bennett JM, Catovsky D, Daniel M-T, et al. Proposals for the classification of the acute leukaemias French-American-British (FAB) co-operative group. Br J Haematol. 1976;33(4):451–458. doi:10.1111/j.1365-2141.1976.tb03563.x
  • Abdul-Hamid G. Classification of Acute Leukemia. Acute Leukemia-The Scientist’s Perspective and Challenge. InTech; 2011; doi:10.5772/19848
  • Segeren C, Vantveer M. The FAB classification for acute myeloid leukaemia? Is it outdated? Neth J Med. 1996;49(3):126–131. doi:10.1016/0300-2977(96)00024-1
  • Onciu M. Acute Lymphoblastic Leukemia. Hematol Oncol Clin North Am. 2009;23(4):655–674. doi:10.1016/j.hoc.2009.04.009
  • Shet A, Jahagirdar B, Verfaillie C. Chronic myelogenous leukemia: mechanisms underlying disease progression. Leukemia. 2002;16(8):1402–1411. doi:10.1038/sj.leu.2402577
  • Oertel J, Kastner M, Bai AR, Kleiner S, Huhn D. Analysis of chronic lymphoid leukaemias according to FAB. Leuk Res. 1992;16(9):919–927. doi:10.1016/0145-2126(92)90037-8
  • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
  • Lin X, Wang J, Huang X, et al. Global, regional, and national burdens of leukemia from 1990 to 2017: a systematic analysis of the global burden of disease 2017 study. Aging. 2021;13(7):10468–10489. doi:10.18632/aging.202809
  • Bochtler T, Haag G-M, Schott S, Kloor M, Krämer A, Müller-Tidow C. Hematological malignancies in adults with a family predisposition. Dtsch Aerzteblatt. 2018;115:848–854. doi:10.3238/arztebl.2018.0848
  • Boström EA, Lira-Junior R. Non-malignant blood disorders and their impact on oral health: an overview. Curr Oral Health Rep. 2019;6(2):161–168. doi:10.1007/s40496-019-0211-9
  • Shallis RM, Ahmad R, Zeidan AM. Aplastic anemia: etiology, molecular pathogenesis, and emerging concepts. Eur J Haematol. 2018;101(6):711–720. doi:10.1111/ejh.13153
  • Rai RK, Fawzi WW, Barik A, Chowdhury A. The burden of iron-deficiency anaemia among women in India: how have iron and folic acid interventions fared? WHO South East Asia J Public Health. 2018;7(1):18–23. doi:10.4103/2224-3151.228423
  • McLean E, Cogswell M, Egli I, Wojdyla D, de Benoist B. Worldwide prevalence of anaemia, WHO vitamin and mineral nutrition information system, 1993–2005. Public Health Nutr. 2009;12(04):444–454. doi:10.1017/S1368980008002401
  • Chowdhury MRK, Rashid MHU, Begum A. Diagnostic role of bone marrow examination in detecting haematological and nonhaematological disorders. Med Today. 2019;31(1):15–18. doi:10.3329/medtoday.v31i1.40315
  • Ozkalemkas F, Ali R, Ozkocaman V, et al. The bone marrow aspirate and biopsy in the diagnosis of unsuspected nonhematologic malignancy: a clinical study of 19 cases. BMC Cancer. 2005;5(1):144. doi:10.1186/1471-2407-5-144
  • Elidrissi Errahhali M, Elidrissi Errahhali M, Boulouiz R, Ouarzane M, Bellaoui M. Distribution and features of hematological malignancies in Eastern Morocco: a retrospective multicenter study over 5 years. BMC Cancer. 2016;16(1):159. doi:10.1186/s12885-016-2205-5
  • Orazi A. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases. Pathobiology. 2007;74(2):97–114. doi:10.1159/000101709
  • Kassahun W, Tesfaye G, Bimerew LG, Fufa D, Adissu W, Yemane T. Prevalence of leukemia and associated factors among patients with abnormal hematological parameters in Jimma Medical Center, Southwest Ethiopia: a cross-sectional study. Adv Hematol. 2020;2020:1–7. doi:10.1155/2020/2014152
  • Belai N, Ghebrenegus AS, Alamin AA, Embaye G, Andegiorgish AK. Patterns of bone marrow aspiration confirmed hematological malignancies in Eritrean National Health Laboratory. BMC Hematol. 2019;19(1):8. doi:10.1186/s12878-019-0138-3
  • Kusum A, Negi G, Gaur DS, et al. Hematological malignancies diagnosed by bone marrow examination in a tertiary hospital at Uttarakhand, India. Indian J Hematol Blood Transfus. 2008;24(1):7–11. doi:10.1007/s12288-008-0016-9
  • Messanh Kueviakoe I. Hematological malignancies: analysis of myelogram results over 21 years in lome teaching hospitals. Clin Med Res. 2015;4(4):111–115. doi:10.11648/j.cmr.20150404.14
  • Baviskar JB. Incidence of acute and chronic leukemias in the rural area at a tertiary care teaching hospital: five years of study. Indian J Pathol Oncol. 2016;3(4):710–713. doi:10.5958/2394-6792.2016.00132.0
  • Elasbali AM, Alharbi HH, Onzi ZA, et al. Epidemiology and patterns of leukemia in Northern Saudi Arabia. Int J Med Res Health Sci. 2019;8(1):160–166.
  • Kibria S, Islam M, Chowdhury A, et al. Prevalence of hematological disorder: a bone marrow study of 177 cases in a private hospital at Faridpur. Faridpur Med Coll J. 1970;5(1):11–13. doi:10.3329/fmcj.v5i1.6806
  • Silva-Junior AL, Alves FS, Kerr MWA, et al. Acute lymphoid and myeloid leukemia in a Brazilian Amazon population: epidemiology and predictors of comorbidity and deaths. PLoS One. 2019;14(8):e0221518. doi:10.1371/journal.pone.0221518
  • Deschler B, Lübbert M. Acute myeloid leukemia: epidemiology and etiology. Cancer. 2006;107(9):2099–2107. doi:10.1002/cncr.22233
  • Tebbi CK. Etiology of acute leukemia: a review. Cancers. 2021;13(9):2256. doi:10.3390/cancers13092256
  • Delgado J, Nadeu F, Colomer D, Campo E. Chronic lymphocytic leukemia: from molecular pathogenesis to novel therapeutic strategies. Haematologica. 2020;105(9):2205–2217. doi:10.3324/haematol.2019.236000
  • Tejaswi V, Lad DP, Jindal N, et al. Chronic lymphocytic leukemia: real-world data from India. JCO Glob Oncol. 2020;(6):866–872. doi:10.1200/GO.20.00032
  • Khan S, Mir A, Khattak BR, et al. Pattern of adulthood hematological malignancies in Khyber Pakhtunkhwa. J Blood Disord Transfus. 2019;10(2):5. doi:10.4172/2155-9864.1000424
  • Silbermann R, Roodman GD. Myeloma bone disease: pathophysiology and management. J Bone Oncol. 2013;2(2):59–69. doi:10.1016/j.jbo.2013.04.001
  • Terpos E, Ntanasis-Stathopoulos I, Gavriatopoulou M, Dimopoulos MA. Pathogenesis of bone disease in multiple myeloma: from bench to bedside. Blood Cancer J. 2018;8(1):7. doi:10.1038/s41408-017-0037-4
  • Ahmad S, Shah KA, Hussain H, et al. Prevalence of acute and chronic forms of leukemia in various regions of Khyber Pakhtunkhwa, Pakistan: needs much more to be done! Bangla J Med Sci. 2019;18(2):222–227. doi:10.3329/bjms.v18i2.40689
  • Bhutani M, Vora A, Kumar L, Kochupillai V. Lympho-hemopoietic malignancies in India. Med Oncol. 2002;19(3):141–152. doi:10.1385/MO:19:3:141
  • Bennett JM, Catovsky D, Daniel MT, et al. The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia: proposals by the French - American - British Cooperative Leukaemia Group. Br J Haematol. 1994;87(4):746–754. doi:10.1111/j.1365-2141.1994.tb06734.x
  • Deschler B, Lübbert M. Acute myeloid leukemia: epidemiology and etiology. Cancer. 2006;107:1–7. doi:10.1002/cncr.22233
  • Vincelli ID, Cufari P, Toscano C, et al. A patient with chronic lymphocytic leukemia, chronic myeloid leukemia and multiple myeloma. Blood. 2020;136(Supplement 1):37. doi:10.1182/blood-2020-141974
  • Onoja A, Otene S, Onoja A, et al. Prevalence and nature of adult hematological malignancies using bone marrow aspiration cytology in a tertiary health facility: a seven year retrospective review. West J Med Biomed Sci. 2021;2(1):39–45. doi:10.46912/wjmbs.39
  • Terwilliger T, Abdul-Hay M. Acute lymphoblastic leukemia: a comprehensive review and 2017 update. Blood Cancer J. 2017;7(6):e577–e577. doi:10.1038/bcj.2017.53
  • Suttorp M, Millot F, Sembill S, Deutsch H, Metzler M. Definition, epidemiology, pathophysiology, and essential criteria for diagnosis of pediatric chronic myeloid leukemia. Cancers. 2021;13(4):798. doi:10.3390/cancers13040798
  • Suresh T, Anjanappa R, Harendra kumar M, Thiyagarajan P. Bone-marrow spectrum in a tertiary care hospital: clinical indications, peripheral smear correlation and diagnostic value. Med JDY Patil Univ. 2015;8(4):490–494. doi:10.4103/0975-2870.160793
  • Riaz H, Shah MA, Ullah I. Frequency of megaloblastic anemia among patients with various hematological disorders after bone marrow examination in peshawar (a tertiary-care hospital study). KJMS. 2018;11(2):318–321.
  • Aslinia F, Mazza JJ, Yale SH. Megaloblastic anemia and other causes of macrocytosis. Clin Med Res. 2006;4(3):236–241. doi:10.3121/cmr.4.3.236
  • Hariz A, Bhattacharya PT. Megaloblastic anemia. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2021.
  • Khan SP, Geelani S, Akhter S, et al. Bone marrow aspiration in haematological disorders: study at a tertiary care centre. Int J Res Med Sci. 2018;6(7):2361–2364.
  • Jha A, Adhikari R, Sarda R. Bone marrow evaluation in patients with fever of unknown origin. J Pathol Nepal. 1970;2(3):231–240. doi:10.3126/jpn.v2i3.6029
  • Orazi A, O’Malley DP, Arber DA. Illustrated pathology of the bone marrow. Cambridge: Cambridge University Press; 2006. Available from: http://ebooks.cambridge.org/ref/id/CBO9780511543531. Accessed January 25, 2022.
  • Gohil M, Rathod K. Bone marrow aspiration cytology study in a Tertiary Care Center, Gujarat, India. Int J Sci Stud. 2018;5(10):11–14.
  • Munir AH, Qayyum S, Gul A, Ashraf Z. Bone marrow aspiration findings in a tertiary care hospital of peshawar. J Postgrad Med Inst. 2015;29(4):297–300.
  • Othieno-Abinya NA, Mwanda WO, Maina MD, Odhiambo AO, Mwanzi SA, Oyiro PO. Haematological parameters in chronic myeloid leukaemia as determinants of clinical manifestations in this disease. J Clin Oncol. 2016;34(15–suppl):e18529–e18529. doi:10.1200/JCO.2016.34.15_suppl.e18529
  • Silva ASJ, Júnior LS, de Oliveira GHM, et al. Evaluation of clinical, hematological and flow cytometry dates in elderly patients with acute myeloid leukemia: impact on clinical outcome. Blood. 2019;134(Supplement–1):5115. doi:10.1182/blood-2019-127319
  • Basabaeen AA, Abdelgader EA, Babekir EA, et al. Clinical presentation and hematological profile among young and old chronic lymphocytic leukemia patients in Sudan. BMC Res Notes. 2019;12(1):202. doi:10.1186/s13104-019-4239-7
  • Chang F, Shamsi TS, Waryah AM. Clinical and hematological profile of acute myeloid leukemia (AML) patients of Sindh. J Hematol Thromboembolic Dis. 2016;04(02). Available from:: http://www.esciencecentral.org/journals/clinical-and-hematological-profile-of-acute-myeloidleukemia-aml-patientsof-sindh-2329-8790-1000239.php?aid=71146.
  • Munir AH, Khan MI. Pattern of basic hematological parameters in acute and chronic leukemias. J Med Sci. 2019;27(2):125–129.